- Home
- DSM vs HRTX Comparison
DSM vs HRTX Comparison
Compare DSM & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.26
Company Overview
Basic Information| Metric | DSM | HRTX |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.5M | 203.5M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | DSM | HRTX |
|---|---|---|
| Price | $6.12 | $1.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 161.7K | ★ 1.8M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $155,097,000.00 |
| Revenue This Year | N/A | $8.98 |
| Revenue Next Year | N/A | $11.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.60 |
| 52 Week Low | $4.69 | $1.00 |
| 52 Week High | $6.05 | $2.68 |
Technical Indicators
Market Signals| Indicator | DSM | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 48.66 |
| Support Level | $6.09 | $1.18 |
| Resistance Level | $6.05 | $1.39 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 71.15 | 46.67 |
Price Performance
Historical Comparison DSM
HRTX
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.